PURPOSE: To investigate whether advanced magnetic resonance (MR) imaging techniques such as diffusion-weighted (DW) and perfusion-weighted (PW) MR imaging and hydrogen 1 (1H) MR spectroscopy can depict functional and pathophysiologic mechanisms in patients who have minor motor deficits (MMDs) associated with human immunodeficiency virus 1 (HIV-1). MATERIALS AND METHODS: Thirty-two patients with results seropositive for HIV-1 and different degrees of HIV-1-related MMD underwent conventional brain MR imaging, as well as DW and PW MR imaging and 1H MR spectroscopy of the basal ganglia. PW MR imaging data were computed pixel by pixel for creation of time-to-peak, relative regional cerebral blood volume, and bolus amplitude parameter maps. In addition, quantitative regional cerebral blood flow (rCBF) maps were calculated with respect to the arterial input function by using the singular value decomposition algorithm. For 1H MR spectroscopy, a stimulated echo acquisition mode 20, or STEAM 20, sequence was used. Spectra were fit for determination of the signal intensities of the different metabolites. According to psychomotor testing results, patients were divided into three groups: group 1, 10 patients with normal motor function; group 2, eight patients with psychomotor slowing for the first time; and group 3, 14 patients who had had sustained pathologic psychomotor slowing for at least 6 months before the MR imaging examination. RESULTS: No patients had an abnormality at either conventional or DW MR imaging. PW MR imaging depicted significantly elevated rCBF in group 2 patients (P =.039, analysis of variance [ANOVA]) and significantly elevated myo-inositol-to-creatine ratio levels in group 3 patients (P =.020, ANOVA). CONCLUSION: Quantitative PW MR imaging and 1H MR spectroscopy can depict pathologic changes in patients who have HIV-1-related MMD but normal clinical examination and conventional MR imaging findings.
PURPOSE: To investigate whether advanced magnetic resonance (MR) imaging techniques such as diffusion-weighted (DW) and perfusion-weighted (PW) MR imaging and hydrogen 1 (1H) MR spectroscopy can depict functional and pathophysiologic mechanisms in patients who have minor motor deficits (MMDs) associated with human immunodeficiency virus 1 (HIV-1). MATERIALS AND METHODS: Thirty-two patients with results seropositive for HIV-1 and different degrees of HIV-1-related MMD underwent conventional brain MR imaging, as well as DW and PW MR imaging and 1H MR spectroscopy of the basal ganglia. PW MR imaging data were computed pixel by pixel for creation of time-to-peak, relative regional cerebral blood volume, and bolus amplitude parameter maps. In addition, quantitative regional cerebral blood flow (rCBF) maps were calculated with respect to the arterial input function by using the singular value decomposition algorithm. For 1H MR spectroscopy, a stimulated echo acquisition mode 20, or STEAM 20, sequence was used. Spectra were fit for determination of the signal intensities of the different metabolites. According to psychomotor testing results, patients were divided into three groups: group 1, 10 patients with normal motor function; group 2, eight patients with psychomotor slowing for the first time; and group 3, 14 patients who had had sustained pathologic psychomotor slowing for at least 6 months before the MR imaging examination. RESULTS: No patients had an abnormality at either conventional or DW MR imaging. PW MR imaging depicted significantly elevated rCBF in group 2 patients (P =.039, analysis of variance [ANOVA]) and significantly elevated myo-inositol-to-creatine ratio levels in group 3 patients (P =.020, ANOVA). CONCLUSION: Quantitative PW MR imaging and 1H MR spectroscopy can depict pathologic changes in patients who have HIV-1-related MMD but normal clinical examination and conventional MR imaging findings.
Authors: Clayton A Wiley; Brian J Lopresti; James T Becker; Fernando Boada; Oscar L Lopez; John Mellors; Carolyn C Meltzer; Stephen R Wisniewski; Chester A Mathis Journal: J Neurovirol Date: 2006-08 Impact factor: 2.643
Authors: Daniel S Bucy; Mark S Brown; Helle Bielefeldt-Ohmann; Jesse Thompson; Annette M Bachand; Michelle Morges; John H Elder; Sue Vandewoude; Susan L Kraft Journal: J Neurovirol Date: 2011-07-23 Impact factor: 2.643
Authors: Sriram Venneti; Brian J Lopresti; Guoji Wang; Stephanie J Bissel; Chester A Mathis; Carolyn C Meltzer; Fernando Boada; Saverio Capuano; Geraldine J Kress; Denise K Davis; James Ruszkiewicz; Ian J Reynolds; Michael Murphey-Corb; Anita M Trichel; Stephen R Wisniewski; Clayton A Wiley Journal: J Clin Invest Date: 2004-04 Impact factor: 14.808
Authors: Anna Kołtowska; Barbara Hendrich; Brygida Knysz; Violetta Sokolska; Marcin Miś; Katarzyna Lubkowska; Michał Furdal; Paweł Szewczyk; Jacek Gąsiorowski; Andrzej Gładysz; Marek Sąsiadek Journal: Pol J Radiol Date: 2010-04
Authors: Charlotte Blokhuis; Henri J M M Mutsaerts; Sophie Cohen; Henriëtte J Scherpbier; Matthan W A Caan; Charles B L M Majoie; Taco W Kuijpers; Peter Reiss; Ferdinand W N M Wit; Dasja Pajkrt Journal: Medicine (Baltimore) Date: 2017-02 Impact factor: 1.889
Authors: Jason G van Genderen; Malon Van den Hof; Anne Marleen Ter Haar; Charlotte Blokhuis; Vera C Keil; Dasja Pajkrt; Henk J M M Mutsaerts Journal: Viruses Date: 2021-10-28 Impact factor: 5.048
Authors: Joanna Bladowska; Brygida Knysz; Anna Zimny; Krzysztof Małyszczak; Anna Kołtowska; Paweł Szewczyk; Jacek Gąsiorowski; Michał Furdal; Marek J Sąsiadek Journal: PLoS One Date: 2014-07-11 Impact factor: 3.240